Implications of protease M/neurosin in myelination during experimental demyelination and remyelination

Neuroscience Letters

Volumn 405, Issue 3, 2006, Pages 175-180

  Bando, Yoshio ^a   Ito, Shinji ^a   Nagai, Yoshiko ^a   Terayama, Ryuji ^a   Kishibe, Mari ^a   Jiang, Ying Ping ^b   Mitrovic, Branka ^b   Takahashi, Takayuki ^c   Yoshida, Shigetaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b BAYER AG   (Germany)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Myelination; Oligodendrocyte; Serine protease

Indexed keywords

CUPRIZONE; CYCLOHEXENE DERIVATIVE; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; GLYCEROPHOSPHATE CALCIUM; MESSENGER RNA; MYELIN BASIC PROTEIN; PROTEASE M; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REMYELINIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; CELLS, CULTURED; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GLUTATHIONE S-TRANSFERASE PI; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; KALLIKREINS; MICE; MICE, INBRED BALB C; MONOAMINE OXIDASE INHIBITORS; MYELIN BASIC PROTEINS; MYELIN SHEATH; OLIGODENDROGLIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746878256     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.06.030     Document Type: Article

References (34)

1. Ansowicz A., Sotiropoulou G., Stenman G., Mok S.C., and Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med. 2 (1996) 624-636
2. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., and Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 11 (2001) 1116-1122
3. Blaber S.I., Ciric B., Christophi G.P., Bernett M.J., Blaber M., Rodriguez M., and Scarisbrick I.A. Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J. 18 7 (2004) 920-922
4. Blaber S.I., Scarisbrick I.A., Bernett M.J., Dhanarajan P., Sceavy M.A., Jin Y., Schwartz M.A., Rodriguez M., and Blaber M. Enzymatic properties of rat myencephalon-specific protease. Biochemistry 41 (2002) 1165-1173
5. Blackmore W.F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocyrol. 1 (1972) 413-426
6. Borgono C.A., and Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4 (2004) 876-890
7. Cammer W. The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro. J. Neurol. Sci. 168 (1999) 116-120
8. Cammer W., Bloom B.R., Norton W.T., and Gordon S. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sci. U.S.A. 75 3 (1978) 1554-1558
9. Diamandis E.P., Yousef G.M., Clements J., Ashworth L.K., Yoshida S., Egelrud T., Nelson P.S., Shiosaka S., Little S., Lilja H., Stenman U.H., Rittenhouse H.G., and Wain H. New nomenclature for the human tissue kallikrein gene family. Clin. Chem. 46 (2000) 1855-1858
10. Diamandis E.P., Yousef G.M., Petraki C., and Soosaipillai A.R. Human kallikrein 6 as a biomarker of alzheimer's disease. Clin. Biochem. 33 8 (2000) 663-667
11. Gao X., Gillig T.A., Ye P., D'Ercole A.J., Matsushima G.K., and Popko B. Interferon-γ protects against cuprizone-induced demyelination. Mol. Cell Neurosci. 16 (2000) 338-349
12. Hall A., Giese N.A., and Richardson W.D. Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGFα-receptors. Development 122 (1996) 4085-4094
13. Hisahara S., Okano H., and Miura M. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci. Res. 46 4 (2003) 387-397
14. Hisahara S., Shoji S., Okano H., and Miura M. ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J. Neurochem. 69 (1997) 10-20
15. Hisahara S., Takano R., Shoji S., Okano H., and Miura M. Role of caspase-1 subfamily in cytotoxic cytokine-induced oligodendrocyte cell death. Neural. Transm. Suppl. 58 (2000) 135-142
16. Hisahara S., Yuan J., Momoi T., Okano H., and Miura M. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J. Exp. Med. 193 1 (2001) 111-122
17. Holgado E.M., Vela J.M., Martin A.A., and Guaza C. LPS/IFN-γ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 13 (2001) 493-502
18. Itoh K., Sakurai Y., Asou H., and Umeda M. Differential expression of alternatively spliced neural cell adhesion molecule L1 isoforms during oligodendrocyte maturation. J. Neurosci. Res. 60 (2000) 579-586
19. Val promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31 2 (2003) 700-707
20. Komoly S., Jeyasingham M.D., Pratt O.E., and Lantos P.L. Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination. J. Neurol. Sci. 79 1-2 (1987) 141-148
21. Ledeen R.W., and Chakraborty G. Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis. Neurochem. Res. 23 3 (1998) 277-289
22. Link H. The cytokine storm in multiple sclerosis. Mult. Scler. 4 1 (1998) 12-15
23. Ludwin S.K. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab. Invest. 39 6 (1978) 597-612
24. Matsui H., Kimura A., Yamashiki N., Moriyama A., Kaya M., Yoshida I., Takagi N., and Takahashi T. Molecular and biochemical characterization of a serine proteinase predominantly expressed in the medulla oblongata and cerebellar white matter of mouse brain. J. Biol. Chem. 275 15 (2000) 11050-11057
25. Scarisbrick I.A., Blaber S.I., Lucchinetti C.F., Genain C.P., Blaber M., and Rodriguez M. Activity of a newly identified serine protease in CNS demyelination. Brain 125 (2002) 1283-1296
26. Scarisbrick I.A., Towner M.D., and Isackson P.J. Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury. J. Neurosci. 17 21 (1997) 8156-8168
27. Seiwa C., Kojima-Aikawa K., Matsumoto I., and Asou H. CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes. J. Neurosci. Res. 69 (2002) 305-317
28. Tansey F.A., and Cammer W. A pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain. J. Neurochem. 57 1 (1991) 95-102
29. Terayama R., Bando Y., Jiang Y.P., Mitrovic B., and Yoshida S. Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis. Neurosci. Lett. 382 (2005) 82-87
30. Terayama R., Bando Y., Takahashi T., and Yoshida S. Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord. Glia 48 2 (2004) 91-101
31. Vartanian T., Li Y., Zhao M., and Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1 7 (1995) 732-743
32. Yamanaka H., He X.P., Matsumoto K., Shiosaka S., and Yoshida S. Protease M/neurosin mRNA is expressed in mature oligodendrocytes. Mol. Brain Res. 71 (1999) 217-224
33. Yamashiro K., Tsuruoka N., Kodama S., Tsujimoto M., Yamamura Y., Tanaka T., Nakazato H., and Yamaguchi N. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochem. Biophys. Acta 1350 1 (1997) 11-14
34. Yousef G.M., Kishi T., and Diamandis E.P. Role of kallikrein enzymes in the central nervous system. Clin. Chim. Acta 329 (2003) 1-8